These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
551 related items for PubMed ID: 2521892
21. Heparan sulfate-chondroitin sulfate hybrid proteoglycan of the cell surface and basement membrane of mouse mammary epithelial cells. David G, Van den Berghe H. J Biol Chem; 1985 Sep 15; 260(20):11067-74. PubMed ID: 3161890 [Abstract] [Full Text] [Related]
24. Purification and analysis of the core protein of the protease-resistant intracellular chondroitin sulfate E proteoglycan from the interleukin 3-dependent mouse mast cell. Stevens RL, Otsu K, Austen KF. J Biol Chem; 1985 Nov 15; 260(26):14194-200. PubMed ID: 3932350 [Abstract] [Full Text] [Related]
25. Multiple classes of heparan sulfate proteoglycans from fibroblast substratum adhesion sites. Affinity fractionation on columns of platelet factor 4, plasma fibronectin, and octyl-sepharose. Lark MW, Culp LA. J Biol Chem; 1984 Jun 10; 259(11):6773-82. PubMed ID: 6327694 [Abstract] [Full Text] [Related]
26. Isolation and partial characterization of heparan sulphate proteoglycan from the human glomerular basement membrane. van den Heuvel LP, van den Born J, van de Velden TJ, Veerkamp JH, Monnens LA, Schroder CH, Berden JH. Biochem J; 1989 Dec 01; 264(2):457-65. PubMed ID: 2532508 [Abstract] [Full Text] [Related]
27. Selective removal of heparan sulfate chains from proteoheparan sulfate with a commercial preparation of heparitinase. Kato M, Oike Y, Suzuki S, Kimata K. Anal Biochem; 1985 Aug 01; 148(2):479-84. PubMed ID: 2932976 [Abstract] [Full Text] [Related]
28. Purification and characterization of protease-resistant secretory granule proteoglycans containing chondroitin sulfate di-B and heparin-like glycosaminoglycans from rat basophilic leukemia cells. Seldin DC, Austen KF, Stevens RL. J Biol Chem; 1985 Sep 15; 260(20):11131-9. PubMed ID: 2411730 [Abstract] [Full Text] [Related]
29. Identification of a 64 kDa heparan sulphate proteoglycan core protein from human lung fibroblast plasma membranes with a monoclonal antibody. de Boeck H, Lories V, David G, Cassiman JJ, van den Berghe H. Biochem J; 1987 Nov 01; 247(3):765-71. PubMed ID: 2447876 [Abstract] [Full Text] [Related]
30. Low-density lipoprotein binding affinity of arterial wall proteoglycans: characteristics of a chondroitin sulfate proteoglycan subfraction. Srinivasan SR, Vijayagopal P, Eberle K, Radhakrishnamurthy B, Berenson GS. Biochim Biophys Acta; 1989 Nov 28; 1006(2):159-66. PubMed ID: 2512982 [Abstract] [Full Text] [Related]
31. Characterization of a heparan sulfate proteoglycan that copurifies with the neural cell adhesion molecule. Cole GJ, Burg M. Exp Cell Res; 1989 May 28; 182(1):44-60. PubMed ID: 2523815 [Abstract] [Full Text] [Related]
32. Lead inhibits the core protein synthesis of a large heparan sulfate proteoglycan perlecan by proliferating vascular endothelial cells in culture. Fujiwara Y, Kaji T. Toxicology; 1999 Apr 15; 133(2-3):159-69. PubMed ID: 10378482 [Abstract] [Full Text] [Related]
33. Release of glomerular heparan-35SO4 proteoglycan by heparin from glomeruli of streptozocin-induced diabetic rats. Klein DJ, Oegema TR, Brown DM. Diabetes; 1989 Jan 15; 38(1):130-9. PubMed ID: 2521210 [Abstract] [Full Text] [Related]
34. Secretion and degradation of lipoprotein lipase in cultured adipocytes. Binding of lipoprotein lipase to membrane heparan sulfate proteoglycans is necessary for degradation. Cisar LA, Hoogewerf AJ, Cupp M, Rapport CA, Bensadoun A. J Biol Chem; 1989 Jan 25; 264(3):1767-74. PubMed ID: 2521485 [Abstract] [Full Text] [Related]
35. Proteoglycans synthesized by an osteoblast-like cell line (UMR 106-01). McQuillan DJ, Findlay DM, Hocking AM, Yanagishita M, Midura RJ, Hascall VC. Biochem J; 1991 Jul 01; 277 ( Pt 1)(Pt 1):199-206. PubMed ID: 1906708 [Abstract] [Full Text] [Related]
36. Heparan sulfate proteoglycans in the substratum adhesion sites of human neuroblastoma cells: modulation of affinity binding to fibronectin. Vallen EA, Eldridge KA, Culp LA. J Cell Physiol; 1988 May 01; 135(2):200-12. PubMed ID: 2967301 [Abstract] [Full Text] [Related]
37. Structural differences between heparan sulphates of proteoglycan involved in the formation of basement membranes in vivo by Lewis-lung-carcinoma-derived cloned cells with different metastatic potentials. Nakanishi H, Oguri K, Yoshida K, Itano N, Takenaga K, Kazama T, Yoshida A, Okayama M. Biochem J; 1992 Nov 15; 288 ( Pt 1)(Pt 1):215-24. PubMed ID: 1445266 [Abstract] [Full Text] [Related]
38. Release of heparan sulfate glycosaminoglycans from proteoglycans in Chinese hamster ovary cells does not require proteolysis of the core protein. Bame KJ. J Biol Chem; 1993 Sep 25; 268(27):19956-64. PubMed ID: 8376358 [Abstract] [Full Text] [Related]
39. Characterization of heparan sulfate proteoglycans synthesized by rat ovarian granulosa cells in culture. Yanagishita M, Hascall VC. J Biol Chem; 1983 Nov 10; 258(21):12857-64. PubMed ID: 6226661 [Abstract] [Full Text] [Related]
40. Lead-induced alteration of heparan sulfate proteoglycans in cultured vascular endothelial cells. Kaji T, Ohkawara S, Nakajima M, Yamamoto C, Fujiwara Y, Miyajima S, Koizumi F. Toxicology; 1997 Mar 14; 118(1):1-10. PubMed ID: 9074649 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]